Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake – a modeling study
Summary Subsidized direct-acting antiviral (DAA) treatment recently became available to all adults living with chronic hepatitis C (HCV) in Australia. Based on rapid uptake (32,600 people initiated DAA in 2016) we estimated the impact on HCV epidemiology and mortality in Australia and determined if Australia can meet the WHO HCV elimination targets by 2030. Using […]
English 
Spanish 
French 
Chinese 
Russian 
Arabic